eosine yellowish-(ys) has been researched along with Insulin Resistance in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Feng, Y; Liu, H; Ping, J; Wen, X; Xu, D; Zhao, W | 1 |
Cao, H; Gao, Y; Huang, Z; Jin, L; Li, B; Ma, X; Mo, S; Wu, J; Zhang, K; Zhi, Y | 1 |
2 other study(ies) available for eosine yellowish-(ys) and Insulin Resistance
Article | Year |
---|---|
Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype.
Topics: Animals; Cholesterol; Eosine Yellowish-(YS); Glucose; Insulin Resistance; Insulins; Lipopolysaccharides; Liver; Macrophages; Mice; Molecular Docking Simulation; Myeloid Differentiation Factor 88; NF-kappa B; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Phenotype; Tea; Theobromine; Toll-Like Receptor 4; Triglycerides | 2022 |
The efficacy and mechanism of Angelica sinensis (Oliv.) Diels root aqueous extract based on RNA sequencing and 16S rDNA sequencing in alleviating polycystic ovary syndrome.
Topics: AMP-Activated Protein Kinases; Angelica sinensis; Animals; DNA, Ribosomal; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Insulin Resistance; Insulins; Letrozole; Peroxisome Proliferator-Activated Receptors; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Sequence Analysis, RNA | 2023 |